3Whit CM, DunnA, Tsikouris, et al. An assessment of the safety of short - tern amiodarone therapy in cardiac surgical patients with fenta- nylisoflurane anesthesia. Anesth Analg, 1999, 89(3) :55.
4Nasr LA, Bouzamondo A, Hulot JS, et al. Prevention of atrial fibrillation onset by beta - blocker, treatment in heart failure : a meta - analysis. Eur Heart J,2007,28:457 -462.
二级参考文献7
1Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation) : developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006,114 : e257-e354.
2Prasad SM, Maniar HS, Camillo CJ, et al. The Cox maze Ⅲ procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures. J Thorac Cardiovasc Surg,2003,126 : 1822-1828.
3Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study.J Am Coll Cardiol,2006 ,48 :2340-2347.
4Oral H, Pappone C, Chugh A, et al. Circumferential pulmonaryvein ablation for chronic atrial fibrillation. N Engl J Med, 2006, 354:934-941.
5Oral H, Chugh A, Ozaydin M, et al. Risk of thromboembolic events after pereutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation,2006,114:759-765.
6Pappone C, Rosanio S, Augello G, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized longterm study. J Am Coll Cardiol,2003,42:185-197.
1Lip GY, Nieuwlaat R, Pisters R, et al. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approachthe Euro Heart Survey on Atrial Fibrillation. Chest, 2010, 137 (2) : 263-272.
2Schmitt J, Duray G, Gersh BJ, et al. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J, 2009, 30 (9) : 1038-1045.
3Zusman O, Amit G, Gilutz H, et al. The significance of new onset atrial fibrillation complicating acute myocardial infarction. Clin Res Cardiol, 2012, 101 (1):17-22.
